Despite this, the risk of stroke can be reduced in a number of patient populations including those with coronary heart disease, diabetes, hypertension, and the elderly by receiving HMG-CoA reductase inhibitors (statins) (Amarenco et al. 2004). This evidence concerns the gene HMGCR and Stroke.